by Johns Hopkins University Bloomberg School of Public Health Credit: Unsplash/CC0 Public Domain The U.S. federal government spent an estimated $1.8 billion in Medicare funds in 2019 on drugs whose clinical benefits have yet to be confirmed by the Food and Drug Administration, a new study led by researchers from the Johns Hopkins Bloomberg School...
